Ray Dalio Bei Gene, Ltd. Transaction History

Bridgewater Associates, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$178.3 - $266.78 $21.4 Million - $32 Million	-119,999 Reduced 90.83%	12,118 $2.16 Million
Q1 2023 May 12, 2023	SELL	$215.53 - $274.5 $12.1 Million - $15.4 Million	-56,248 Reduced 29.86%	132,117 $28.5 Million
Q4 2022 Feb 13, 2023	SELL	$125.51 - $229.3 $18.6 Million - $34 Million	-148,132 Reduced 44.02%	188,365 $41.4 Million
Q3 2022 Nov 10, 2022	BUY	$131.8 - $202.24 $705,789 - $1.08 Million	5,355 Added 1.62%	336,497 $45.4 Million
Q2 2022 Aug 11, 2022	SELL	$121.11 - $216.05 $6.38 Million - $11.4 Million	-52,676 Reduced 13.72%	331,142 $53.6 Million
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $22.6 Million - $41.6 Million	154,335 Added 67.25%	383,818 $72.4 Million
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $13.3 Million - $20.9 Million	53,560 Added 30.45%	229,483 $62.2 Million
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $22.4 Million - $36.2 Million	89,877 Added 104.45%	175,923 $63.9 Million
Q2 2021 Aug 13, 2021	BUY	$292.75 - $367.01 $3.8 Million - $4.77 Million	12,993 Added 17.79%	86,046 $29.5 Million
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $13.6 Million - $20 Million	52,254 Added 251.23%	73,053 $25.4 Million
Q4 2020 Feb 12, 2021	BUY	$221.31 - $316.61 $4.6 Million - $6.59 Million	20,799 New	20,799 $5.37 Million

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.